HIZENTRA 200 MG/ML INJ FV 50 ML
(Immunoglobuline humaine normale) - Maladie rare sans désignation orpheline
* Replacement therapy in adults and children in primary immunodeficiency syndromes such as:
- congenital agammaglobulinaemia and hypogammaglobulinaemia,
- common variable immunodeficiency,
- severe combined immunodeficiency,
- IgG subclass deficiencies with recurrent infections.
* Replacement therapy in myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.